The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Seven-Year Weight Trajectories and Health Outcomes in the Longitudinal Assessment of Bariatric Surgery (LABS) Study
Open accessAbstract
Importance: More information is needed about the durability of weight loss and health improvements after bariatric surgical procedures. Objective: To examine long-term weight change and health status following Roux-en-Y gastric bypass (RYGB) and laparoscopic adjustable gastric banding (LAGB). Design, Setting, and Participants: The Longitudinal Assessment of Bariatric Surgery (LABS) study is a multicenter observational cohort study at 10 US hospitals in 6 geographically diverse clinical centers. Adults undergoing bariatric surgical procedures as part of clinical care between 2006 and 2009 were recruited and followed up until January 31, 2015. Participants completed presurgery, 6-month, and annual research assessments for up to 7 years. Main Outcome and Measures: Percentage of weight change from baseline, diabetes, dyslipidemia, and hypertension, determined by physical measures, laboratory testing, and medication use. Results: Of 2348 participants, 1738 underwent RYGB (74%) and 610 underwent LAGB (26%). For RYBG, the median age was 45 years (range, 19-75 years), the median body mass index (calculated as weight in kilograms divided by height in meters squared) was 47 (range, 34-81), 1389 participants (80%) were women, and 257 participants (15%) were nonwhite. For LAGB, the median age was 48 years (range, 18-78), the body mass index was 44 (range, 33-87), 465 participants (76%) were women, and 63 participants (10%) were nonwhite. Follow-up weights were obtained in 1300 of 1569 (83%) eligible for a year-7 visit. Seven years following RYGB, mean weight loss was 38.2 kg (95% CI, 36.9-39.5), or 28.4% (95% CI, 27.6-29.2) of baseline weight; between years 3 and 7 mean weight regain was 3.9% (95% CI, 3.4-4.4) of baseline weight. Seven years after LAGB, mean weight loss was 18.8 kg (95% CI, 16.3-21.3) or 14.9% (95% CI, 13.1-16.7), with 1.4% (95% CI, 0.4-2.4) regain. Six distinct weight change trajectory patterns for RYGB and 7 for LAGB were identified. Most participants followed trajectories in which weight regain from 3 to 7 years was small relative to year-3 weight loss, but patterns were variable. Compared with baseline, dyslipidemia prevalence was lower 7 years following both procedures; diabetes and hypertension prevalence were lower following RYGB only. Among those with diabetes at baseline (488 of 1723 with RYGB [28%]; 175 of 604 with LAGB [29%]), the proportion in remission at 1, 3, 5, and 7 years were 71.2% (95% CI, 67.0-75.4), 69.4% (95% CI, 65.0-73.8), 64.6% (95% CI, 60.0-69.2), and 60.2% (95% CI, 54.7-65.6), respectively, for RYGB and 30.7% (95% CI, 22.8-38.7), 29.3% (95% CI, 21.6-37.1), 29.2% (95% CI, 21.0-37.4), and 20.3% (95% CI, 9.7-30.9) for LAGB. The incidence of diabetes at all follow-up assessments was less than 1.5% for RYGB. Bariatric reoperations occurred in 14 RYGB and 160 LAGB participants. Conclusions and Relevance: Following bariatric surgery, different weight loss patterns were observed, but most participants maintained much of their weight loss with variable fluctuations over the long term. There was some decline in diabetes remission over time, but the incidence of new cases is low following RYGB. Trial Registration: clinicaltrials.gov Identifier: NCT00465829.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Four studies with a follow-up of at least 5 years were identified. Port-related and band-related complications were documented for 18%, 23%, 27% and 43% of patients [78, 80, 85, 89].”
In the citing paper
“Re-interventions for insufficient weight loss were reported by 3 studies at follow-up > 5 years, and documented for 6%, 12% and 18% of patients [78, 80, 85].”
In the citing paper
“the Longitudinal Assessment of Bariatric Surgery (LABS) study reported a 3.9% WR 3–7 years after RYGB [34].”
In the citing paper
“T2D predicted WR and IWL [34, 79–81, 86]”
In the citing paper
“research suggested that male gender was associated with suboptimal or worse WL after RYGB [34, 78].”
In the citing paper
“hypertension and low HDL cholesterol were both associated with poor weight trajectory [34].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 3-Year Outcomes
Schauer, P. R., Bhatt, D. L., Kirwan, J. P., Wolski, K., Brethauer, S. A., Navaneethan, S. D., Aminian, A., Pothier, C. E., Kim, E. S. H., Nissen, S. E., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401329 · Cited by 1,901
Structural Equation Modeling: Applications Using Mplus
Wang, J., & Wang, X. (2012) · Cited by 1,326
Sjöström, L., Peltonen, M., Jacobson, P., Ahlin, S., Andersson-Assarsson, J., Anveden, Å., Bouchard, C., Carlsson, B., Karason, K., Lönroth, H., et al. (2014) · JAMA · doi:10.1001/jama.2014.5988 · Cited by 1,054
Long-term Follow-up After Bariatric Surgery: A Systematic Review
Puzziferri, N., Roshek, T. B., Mayo, H. G., Gallagher, R., Belle, S. H., & Livingston, E. H. (2014) · JAMA · doi:10.1001/jama.2014.10706 · Cited by 819
Self-citationCourcoulas, A. P. (2013) · JAMA · doi:10.1001/jama.2013.280928 · Cited by 799
Self-citationBariatric surgery and prevention of type 2 diabetes in Swedish obese subjects
Carlsson, L. M. S., Peltonen, M., Ahlin, S., Anveden, Å., Bouchard, C., Carlsson, B., Jacobson, P., Lönroth, H., Maglio, C., Näslund, I., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112082 · Cited by 794
Bariatric Surgery and Long-term Durability of Weight Loss
Maciejewski, M. L., Arterburn, D. E., Van Scoyoc, L., Smith, V. A., Yancy, W. S., Weidenbacher, H. J., Livingston, E. H., & Olsen, M. K. (2016) · JAMA Surgery · doi:10.1001/jamasurg.2016.2317 · Cited by 720
Health benefits of gastric bypass surgery after 6 years
Adams, T. D., Davidson, L. E., Litwin, S. E., Kolotkin, R. L., LaMonte, M. J., Pendleton, R. C., Strong, M. B., Vinik, R., Wanner, N. A., Hopkins, P. N., et al. (2012) · JAMA · doi:10.1001/2012.jama.11164 · Cited by 674
Courcoulas, A. P., Belle, S. H., Neiberg, R. H., Pierson, S. K., Eagleton, J. K., Kalarchian, M. A., DeLany, J. P., Lang, W., & Jakicic, J. M. (2015) · JAMA Surgery · doi:10.1001/jamasurg.2015.1534 · Cited by 376
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 698
White, G. E., Courcoulas, A. P., Richardson, G. A., Mair, C., & King, W. C. (2018) · Annals of Surgery · doi:10.1097/sla.0000000000003078 · Cited by 18
“B ariatric surgery results in long-term weight loss, remission of obesity-related comorbidities, and reduced all-cause mortality.(1,2) Roux-en-Y gastric bypass (RYGB) is one of the most common bariatric procedures performed in the United States,(3) likely due to its impressive long-term outcomes.”
BackgroundSelf-citationPrice, J. A., Zickgraf, H. F., & Rigby, A. (2019) · Public Health Nutrition · doi:10.1017/s1368980019001320 · Cited by 18
Mortality after bariatric surgery: findings from a 7-year multicenter cohort study
White, G. E., Courcoulas, A. P., King, W. C., Flum, D. R., Yanovski, S. Z., Pomp, A., Wolfe, B. M., Spaniolas, K., Pories, W. J., & Belle, S. H. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.08.015 · Cited by 18
Self-citationMusbahi, A., Brown, L. R., Reddy, A., Viswanath, Y. K. S., Rao, M., & Gopinath, B. (2019) · International Journal of Surgery · doi:10.1016/j.ijsu.2019.12.021 · Cited by 18
Conceição, E., de Lourdes, M., Moreira, L., Pinto‐Bastos, A., & Félix, S. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2020.03.005 · Cited by 18
Understanding the pathophysiologic pathways that underlie obesity and options for treatment
Kumar, R. B., Srivastava, G., Reid, T. J., & Aronne, L. J. (2021) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2021.1991310 · Cited by 20
Blom-Høgestøl, I. K., Aasbrenn, M., Chahal-Kummen, M., Brunborg, C., Eribe, I., Kristinsson, J. A., Farup, P. G., & Mala, T. (2019) · BMC Gastroenterology · doi:10.1186/s12876-019-1103-0 · Cited by 18
Feig, E. H., Harnedy, L. E., Golden, J., Thorndike, A. N., Huffman, J. C., & Psaros, C. (2022) · Obesity Surgery · doi:10.1007/s11695-021-05807-x · Cited by 16
“Obesity is a major public health concern, and metabolic and bariatric surgery (MBS) is the most effective treatment available for severe obesity [1].”
BackgroundWhat About My Weight? Insufficient Weight Loss or Weight Regain After Bariatric Metabolic Surgery
Zefreh, H., Amani‐Beni, R., Sheikhbahaei, E., Farsi, F., Ahmadkaraji, S., Barzin, M., Darouei, B., Khalaj, A., & Shahmiri, S. S. (2023) · Intern J Endocrinol Metab · doi:10.5812/ijem-136329 · Cited by 19
“As for IWL, the prevalence of WR after LSG (31, 32) and after RYGB, one-anastomosis gastric bypass (OAGB), and LSG combined (33) were 32 - 40% and 20%, respectively.”
BackgroundInfluentialBjornstad, P., Nehus, E. J., Jenkins, T. M., Mitsnefes, M. M., Moxey‐Mims, M., Dixon, J. B., & Inge, T. H. (2020) · Kidney International · doi:10.1016/j.kint.2020.01.016 · Cited by 17
Mou, D., de Vries, C. E. E., Pater, N., Poulsen, L., Makarawung, D. J. S., Wiezer, M. J., van Veen, R. N., Hoogbergen, M. M., Sørensen, J. A., Klassen, A. F., et al. (2020) · Surgical Endoscopy · doi:10.1007/s00464-020-07886-w · Cited by 17
The Impact of Ethnicity on Metabolic Outcomes After Bariatric Surgery
Valencia, A., Garcia, L. C., & Morton, J. M. (2019) · Journal of Surgical Research · doi:10.1016/j.jss.2018.09.061 · Cited by 17
Self-citationMarin, R.-C., Radu, A.-F., Negru, P. A., Radu, A.-F., Negru, D. C., Aron, R. A. C., Bodog, T. M., Bodog, R. F., Maghiar, P. B., & Brata, R. D. (2024) · Medicina · doi:10.3390/medicina61010014 · Cited by 21
“Also, it was demonstrated that 68% of patients considering MBS who are severely obese also have hypertension [138].”
InfluentialBariatric surgery for treatment of morbid obesity in adults
Park, K. B., & Jun, K. (2024) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2024.219 · Cited by 17
“Among individuals seeking bariatric surgery for severe obesity, approximately 64% have dyslipidemia, characterized by high levels of low-density lipoprotein, elevated triglycerides, and low levels of high-density lipoprotein [56].”
Morais, T., Seabra, A. L., Patrício, B. G., Guimarães, M., Nora, M. C., Oliveira, P. F., Alves, M. G., & Monteiro, M. P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115695 · Cited by 16
“Several BCAAs and other essential AAs are known to be involved in glucose homeostasis [23].”
BackgroundPsychosocial Functioning of Bariatric Surgery Patients 6-Years Postoperative
Marek, R. J., Martin‐Fernandez, K. W., Ben‐Porath, Y. S., & Heinberg, L. J. (2020) · Obesity Surgery · doi:10.1007/s11695-020-05025-x · Cited by 17
Betensky, D. J., Smith, K. C., Katz, J. N., Yang, C. J., Hunter, D. J., Collins, J. E., Feldman, C. H., Messier, S. P., Kim, J., Selzer, F., et al. (2025) · Annals of Internal Medicine · doi:10.7326/annals-24-03609 · Cited by 15
Leyaro, B. J., Howie, L., McMahon, K. R., Ali, A., & Carragher, R. (2024) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2024.116151 · Cited by 15
Impact of weight trajectory after bariatric surgery on co-morbidity evolution and burden
Davis, J. A., & Saunders, R. (2020) · BMC Health Services Research · doi:10.1186/s12913-020-5042-9 · Cited by 15
Surgical and Nonsurgical Weight Loss for Patients with Obstructive Sleep Apnea
Saunders, K. H., Igel, L. I., & Tchang, B. G. (2020) · Otolaryngologic Clinics of North America · doi:10.1016/j.otc.2020.02.003 · Cited by 14
Fischer, H. J., Weiss, R. E., Friedman, A. N., Imam, T. H., & Coleman, K. J. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2020.11.010 · Cited by 17
“Modest weight regain such as what occurred after the weight nadir is also common.(40) Within the first two months following surgery, we also observed an immediate and large rise in eGFR that could reflect a real improvement in glomerular filtration, a spurious effect from reduced muscle mass leading to a lower serum c…”
BackgroundLassen, P. B., Nori, N., Bédossa, P., Genser, L., Aron‐Wisnewsky, J., Poitou, C., Surabattula, R., Nielsen, M. J., Karsdal, M. A., Leeming, D. J., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab897 · Cited by 15
Paul, L., van der Heiden, C., van Hoeken, D., Deen, M. L., Vlijm, A., Klaassen, R. A., Biter, L. U., & Hoek, H. W. (2022) · International Journal of Eating Disorders · doi:10.1002/eat.23825 · Cited by 15
“As weight regain mainly occurs after the second year postoperative (Courcoulas et al., 2018), the three- and five-year follow-ups were carried out as planned to determine whether weight change differences between groups occurred at long-term follow-up.”
BackgroundDecision Regret up to 4 Years After Gastric Bypass and Gastric Banding
Wee, C. C., Fleishman, A., McCarthy, A. C., Hess, D. T., Apovian, C. M., & Jones, D. B. (2019) · Obesity Surgery · doi:10.1007/s11695-019-03772-0 · Cited by 15
Shah, E., Al-Shiab, R., Abdo, A., Özbek, L., Covic, A. C., & Kanbay, M. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70713 · Cited by 17
Behari, J., Graham, L., Wang, R., Schirda, C., Borhani, A. A., Methé, B. A., Li, K. W., Morris, A. M., Luu, H. N., Palmieri, S., et al. (2020) · Obesity Science & Practice · doi:10.1002/osp4.476 · Cited by 14
“Differential responses to weight loss intervention have also been reported for patients undergoing weight loss surgery and deserve further research.(31) The microbiota is characterized by a complex arrangement of trillions of microbial cells partitioned into hundreds to thousands of species.”
BackgroundMarijuana and Bariatric Surgery
Diggins, A. D., & Heinberg, L. J. (2021) · Current Psychiatry Reports · doi:10.1007/s11920-020-01218-4 · Cited by 15
Weighing in on Type 2 Diabetes Remission
Meerasa, A., & Dash, S. (2021) · Diabetes Care · doi:10.2337/dci21-0041 · Cited by 17
“Weight regain is associated with relapse of T2D (4,10,11).”
BackgroundBouchard‐Mercier, A., de Toro‐Martín, J., Nadeau, M., Lescelleur, O., Lebel, S., Richard, D., Biertho, L. D., Tchernof, A., & Vohl, M. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03485-6 · Cited by 15
Lynch, A. I., Kozak, A. T., & Zalesin, K. C. (2022) · Appetite · doi:10.1016/j.appet.2022.106271 · Cited by 15
Cardiometabolic Improvements After Metabolic Surgery and Related Presurgery Factors
Wang, L., O’Brien, M. T., Zhang, X., Chen, Y., English, W. J., Williams, B., Spann, M. D., Albaugh, V. L., Shu, X., Flynn, C. R., et al. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae027 · Cited by 13
Goldstein, S. P., Thomas, J. G., Vithiananthan, S., Blackburn, G. L., Jones, D. B., Webster, J., Jones, R. N., Evans, E. W., Dushay, J. R., Moon, J., et al. (2018) · BMC Obesity · doi:10.1186/s40608-018-0204-6 · Cited by 14
“However, there is substantial individual variability in short- and long-term weight loss [6, 7].”
BackgroundRaatz, S. K., Johnson, L. K., Caliquary, A., King, W. C., Kalarchian, M. A., Devlin, M. J., Marcus, M. D., & Mitchell, J. E. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2020.04.007 · Cited by 15
“The pattern of greatest weight loss achievement at two years in these participants is similar to that observed in the entire RYGB LABS-2 cohort (3).”
ResultSelf-citationObesity and climate change: co-crises with common solutions
Behrens, P., Champagne, C. M., Halford, J. C. G., Moodie, M., Proietto, J., Rutter, G. A., Samaras, K., & Holly, J. M. P. (2025) · Frontiers in Science · doi:10.3389/fsci.2025.1613595 · Cited by 13
Melendez-Araújo, M. S., Berber, L. C. L., de Sousa, K. M. Q., Figueiredo, A. C. M. G., Lamarca, F., Dutra, E. S., & de Carvalho, K. M. B. (2022) · Obesity Surgery · doi:10.1007/s11695-022-06269-5 · Cited by 14
“The mechanisms involved in these associations are complex and need further clarification [2].”
BackgroundAssessing the state of obesity care: Quality, access, guidelines, and standards
Kaplan, L. M., Apovian, C. M., Ard, J. D., Allison, D. B., Aronne, L. J., Batterham, R. L., Busetto, L., Dicker, D., Horn, D. B., Kelly, A. S., et al. (2024) · Obesity Science & Practice · doi:10.1002/osp4.765 · Cited by 15
“Long ‐ term average weight loss in adults following the most common current metabolic/ bariatric procedures ranges between 20% and 30%, 63 exceeding long ‐ term average weight loss achieved through lifestyle (~4”
BackgroundSelf-citationBillmann, F. G., Shishtawi, S. E., Bruckner, T., ElSheikh, M., Müller-Stich, B. P., & Billeter, A. T. (2021) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn-21-71 · Cited by 12
“Therefore, there is a need for medium-to long-term studies to specifically examine the metabolic effects of bariatric surgery in obese patients with NAFLD and T2DM, particularly given that these co-morbidities are associated with the highest risk of progression of NAFLD to cirrhosis and HCC.”
Kostic, A. M., Leifer, V. P., Gong, Y., Robinson, M. K., Collins, J. E., Neogi, T., Messier, S. P., Hunter, D. J., Selzer, F., Suter, L. G., et al. (2022) · Arthritis Care & Research · doi:10.1002/acr.24967 · Cited by 13
“cohort, derived from baseline data from the Longitudinal Assessment of Bariatric Surgery (LABS) study, a large, multicenter, observational, prospective study that collected outcomes data up to 7 years following bariatric surgery, including RYGB and LSG (12).”
MethodInfluentialA review on the beneficial effects of bariatric surgery in the management of obesity
Wahab, R. A., & le Roux, C. W. (2022) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2022.2110865 · Cited by 19
Tankel, J., Shlezinger, O., Neuman, M., Hershko‐Moshe, A., Nachum, N. B., Hurvitz, N., & Spira, R. M. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04462-y · Cited by 13
Ivezaj, V., Kalarchian, M. A., King, W. C., Devlin, M. J., Mitchell, J. E., & Crosby, R. D. (2022) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2022.04.015 · Cited by 13
Self-citationRen, M., Zhou, X., Lv, L., & Ji, F. (2022) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2021.00448 · Cited by 12
Xie, L., Almandoz, J. P., Mathew, M. S., Schellinger, J. N., Kapera, O., Ngenge, S., Marroquin, E. M., McAdams, C. J., Kukreja, S. S., Schneider, B. E., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.47431 · Cited by 12
Characteristics of Patients Lost to Follow-up after Bariatric Surgery
Krietenstein, L., Koschker, A., Miras, A. D., Kollmann, L., Gruber, M., Dischinger, U., Haubitz, I., Faßnacht, M., Warrings, B., & Seyfried, F. (2024) · Nutrients · doi:10.3390/nu16162710 · Cited by 13
“In line with the literature, %TWL was 30% two years after surgery and stabilised at about 27% after five years [1,2,39,40], with no differences between IFU and LTFU cohorts.”
MethodResultvan Reekum, E. A., Darcy, M., Drage, J., Xu, J., Ng, K., Forestell, B., Santesso, N. A., Joundi, R. A., Wong, J. A., Doumouras, A. G., et al. (2025) · Obesity Reviews · doi:10.1111/obr.13968 · Cited by 12
“Heterogeneity was evaluated statistically with the I 2 statistic and explored with a pre-specified subgroup analysis by year after surgery ( ≤ 2 years vs > 2 years), as weight and comorbidity recurrence may begin 2 years after surgery [51].”
Burger, P. M., Monpellier, V. M., Deden, L. N., Kooiman, L., Liem, R. S. L., Hazebroek, E. J., Janssen, I. M. C., & Westerink, J. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2020.07.011 · Cited by 12
Silveira, F. C., Docherty, N. G., Sallet, P. C., Moraes, M., Monclaro, T. V., Arruda, M., Pizani, C., Sallet, J. A. A. S., & le Roux, C. W. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04942-1 · Cited by 11
Preoperative inhibitory control predicts weight loss 1 year after bariatric surgery
Walø‐Syversen, G., Kvalem, I. L., Kristinsson, J. A., Eribe, I., Rø, Ø., Brunborg, C., & Dahlgren, C. L. (2020) · European Eating Disorders Review · doi:10.1002/erv.2801 · Cited by 11
Franken, R. J., & van de Laar, A. W. J. M. (2023) · Obesity Surgery · doi:10.1007/s11695-023-06586-3 · Cited by 12
“identified weight trajectories in the Longitudinal Assessment of Bariatric Surgery (LABS) cohort of 2348 participants [10].”
BackgroundWeight loss trend after bariatric surgery in a population of obese patients
Palumbo, P., Banchelli, F., Miloro, C., Toschi, P. F., Mécheri, F., Gabriele, S., Pantaleoni, M., D’Amico, R., & Menozzi, R. (2023) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2023.06.015 · Cited by 12
Kwon, Y., Jang, M., Lee, Y., Ha, J., & Park, S. S. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082348 · Cited by 12
“Bariatric surgery is currently the most successful and durable treatment for the morbidly obese [1–3]; however, there is wide variability in the weight loss response to bariatric surgery [4–6] and over 20% of bariatric patients experience long-term postoperative weight regain [2,7,8].”
BackgroundAnugwom, C. M., Thomson, M., FREESE, R. L., Lake, J. R., & Lim, N. (2023) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2022-001083 · Cited by 12
Axer, S. S., Lederhuber, H., Stiede, F., Szabó, É., & Näslund, I. (2023) · Obesity Surgery · doi:10.1007/s11695-023-06630-2 · Cited by 11
“To choose the index operation as reference point implies a higher interest in the effects of bariatric surgery as an entity offering the opportunity to analyse individual weight trajectories [34].”
BackgroundSlurink, I. A. L., Nyklı́ček, I., Kint, R., Tak, D. J. A. M., Schiffer, A. A., Langenhoff, B. S., Ouwens, M. A., & Soedamah‐Muthu, S. S. (2024) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2024.111590 · Cited by 11
Bariatric Surgery and Weight Gain: Bibliometric Analysis
Seçkin, D., & Cebeci, F. (2024) · Obesity Surgery · doi:10.1007/s11695-024-07055-1 · Cited by 12
“Studies show that patients losing 20–30% of their total weight within a year or two after surgery will regain 7% of the lowest weight averages they have reached in 10 years [6–8].”
BackgroundObesity-Related Glomerulopathy: Epidemiology, Pathogenesis, and Current Treatments
Yang, X., Bayliss, G. P., & Zhuang, S. (2024) · Integrative Medicine in Nephrology and Andrology · doi:10.1097/imna-d-24-00011 · Cited by 12
“[66] Although weight loss from bariatric surgery is more pronounced, complications cannot be ignored.”
Kovac, L., Gancheva, S., Jähnert, M., Sehgal, R., Mastrototaro, L., Schlensak, M., Granderath, F. A., Rittig, K., Roden, M., Schürmann, A., et al. (2024) · Diabetes & Metabolism · doi:10.1016/j.diabet.2024.101561 · Cited by 11
Cardioprotective benefits of metabolic surgery and GLP-1 receptor agonist–based therapies
Morissette, A., & Mulvihill, E. E. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.07.012 · Cited by 12
Short-term results of long biliopancreatic limb Roux-en-Y gastric bypass—is it superior?
Moon, R. C., Bornstein, A., Teixeira, A. F., & Jawad, M. A. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.12.021 · Cited by 11
de Lourdes, M., Cerqueira, L., Pinto‐Bastos, A., Marôco, J. P., Palmeira, L., Brandão, I., Vaz, A. R., & Conceição, E. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10132967 · Cited by 11
“Bariatric surgery is currently the most effective and durable treatment for severe obesity, resulting in significant weight loss and substantial improvements in obesity-related comorbidities [1] and patients’ psychosocial function [2].”
BackgroundLee, E., Kawaguchi, E. S., Zhang, J., Kim, S. E., Deapen, D., Liu, L., Sheidaee, N., Hwang, A. E., Kang, I. M., Sandhu, K. K., et al. (2021) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2021.09.017 · Cited by 11
Weight loss before bariatric surgery and its impact on poor versus excellent outcomes at 2 years
Rodríguez, F., Herrera-González, A., Sepúlveda, E. M., Guilbert, L., Hernández, L. A., Peñuñuri, L. F., Rodríguez, F. M., & Zerrweck, C. (2022) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-021-02399-z · Cited by 11
“Patients with longer duration of T2DM, insulin use, and poor glycemic control prior to surgery have been identified to be most likely to experience non-remission [33].”
BackgroundBariatric Surgeon Perspective on Revisional Bariatric Surgery (RBS) for Weight Recurrence
Giannopoulos, S., Kapsampelis, P., Pokala, B., Connors, J. D. N., Hilgendorf, W. A., Timsina, L., Clapp, B. L., Ghanem, O. M., Kindel, T. L., & Stefanidis, D. (2023) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2023.02.027 · Cited by 11
Kapała, J. M., Maroszczuk, T., Lewandowska, J. A., Lech, P., & Dowgiałło‐Gornowicz, N. (2023) · Medicina · doi:10.3390/medicina59040766 · Cited by 12
“Although patterns varied, the majority of patients followed trajectories in which they regained weight from 3 to 7 years after the surgery [13].”
BackgroundVariation by race/ethnicity in the utilization and weight loss following metabolic bariatric surgery
Chen, G., Donahoo, W. T., Cardel, M. I., Holgerson, A. A., Ayzengart, A., Johnson-Mann, C. N., & Gurka, M. J. (2023) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2023.06.007 · Cited by 11
Thaker, V., Kwee, L. C., Chen, H., Bahnson, J. L., Ilkayeva, O., Muehlbauer, M. J., Wolfe, B. M., Purnell, J. Q., Pi-Sunyer, X., Newgard, C. B., et al. (2023) · Obesity · doi:10.1002/oby.23943 · Cited by 11
“Results of longitudinal follow-up of LABS-2 participants, including impact on T2D, have been previously reported [15,16].”
BackgroundSelf-citationConceição, E., Pinto‐Bastos, A., de Lourdes, M., Brandão, I., Teixeira, C., & Machado, P. P. P. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.02.011 · Cited by 11
End‐of‐Trial Health Outcomes in Look AHEAD Participants who Elected to have Bariatric Surgery
Wadden, T. A., Chao, A. M., Bahnson, J. L., Bantle, J. P., Clark, J. M., Gaussoin, S. A., Jakicic, J. M., Johnson, K., Miller, G. D., Unick, J. L., et al. (2019) · Obesity · doi:10.1002/oby.22411 · Cited by 14
“However, LAGB is no longer widely used in the United States because of lesser longterm benefits as compared with RYGB and SG (13,16,17).”
BackgroundSelf-citationPokala, B., Giannopoulos, S., Athanasiadis, D. I., Motamedi, S. M. K., & Stefanidis, D. (2022) · Surgical Endoscopy · doi:10.1007/s00464-022-09719-4 · Cited by 11
Sperb, L. F., Leotti, V. B., Silveiro, S. P., de Azevedo, M. J., & Viana, L. V. (2023) · Obesity Surgery · doi:10.1007/s11695-022-06448-4 · Cited by 10
“Despite some participants being at the regain weight phase, the remission rate of chronic diseases related to severe obesity plus sustained weight loss was comparable with other successful results expected for the post-RYGB procedure state [41, 42].”
ResultLeven, C., Delavenne, X., Roche, C., Bressollette, L., Couturaud, F., Lacut, K., & Thereaux, J. (2024) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2024.06.024 · Cited by 11
Badorrek, S., Franklin, J., McBride, K. A., Conway, L. J., & Williams, K. (2024) · Obesity Reviews · doi:10.1111/obr.13829 · Cited by 10
Jaensson, M., Dahlberg, K., Nilsson, U. G., & Stenberg, E. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-027272 · Cited by 10
“However, the long-term efficacy of bariatric surgery differs between individuals.(9) In terms of complications, individual characteristics such as age (>50 years), specific obesity-related comorbidities and intraoperative adverse events such as bleeding are associated with increased postoperative complication rates.”
BackgroundCastagneto‐Gissey, L., Casella-Mariolo, J., & Mingrone, G. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_565 · Cited by 11
Blom-Høgestøl, I. K., Mala, T., Kristinsson, J. A., Brunborg, C., Gulseth, H. L., & Eriksen, E. F. (2019) · Bone · doi:10.1016/j.bone.2019.115069 · Cited by 10
Davis, J. A., & Saunders, R. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.19545 · Cited by 10
Fennern, E. B., Farjah, F., Chen, J. Y., Verdial, F. C., Cook, S. B., Wolff, E. M., & Khandelwal, S. (2020) · Surgical Endoscopy · doi:10.1007/s00464-020-08049-7 · Cited by 10
Testosterone Therapy for Prevention and Treatment of Obesity in Men
Caliber, M., & Saad, F. (2020) · Androgens Clinical Research and Therapeutics · doi:10.1089/andro.2020.0010 · Cited by 11
Huang, Y., Lin, Y., Lee, W., Hur, K. Y., Kasama, K., Cheng, A. K. S., Lee, M., Wong, S. K., Soong, T., Lee, K., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14279 · Cited by 11
“Sustained improvement in cholesterol and TG levels was reported in the LABS-2 study up to 7 years.(46) Although the change patterns of individual variables differed, the lipid profile improved significantly through 5 years in the current study, and this effect was similar between procedures, except for the low improve…”
BackgroundResultInfluentialWeight-loss thresholds after bariatric surgery and cardiovascular outcomes: more is better
Jiménez, A., Pané, A., Ibarzábal, A., de Hollanda, A., Tundidor, D., Balibrea, J. M., Andreu, A., Molero, J., Cañizares, S., Obach, A., et al. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-00986-0 · Cited by 12
Psychosocial and behavioral correlates of weight loss 12 to 15 years after bariatric surgery
Martin‐Fernandez, K. W., Creel, D. B., & Schuh, L. M. (2021) · Journal of Behavioral Medicine · doi:10.1007/s10865-021-00263-5 · Cited by 12
Computational approaches to predicting treatment response to obesity using neuroimaging
Kozarzewski, L., Maurer, L., Mähler, A., Spranger, J., & Weygandt, M. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09701-w · Cited by 9
Wojciechowska, G. E. P., Szczerbiński, Ł., Krętowski, M., Niemira, M., Hady, H. R., & Kretowski, A. J. (2022) · Obesity · doi:10.1002/oby.23342 · Cited by 9
“SG is a simpler surgery procedure but it has a lower T2D remission rate than Roux- enY gastric bypass (RYGB) (4,11).”
BackgroundInfluentialOlsson, L. M., Borgeraas, H., Chakaroun, R., Hofsø, D., Hertel, J. K., Dwibedi, C. K., Mitteregger, M., Holst, J. J., Tremaroli, V., Hjelmesaeth, J. S., et al. (2026) · Nature Metabolism · doi:10.1038/s42255-026-01525-9 · Cited by 10
“However, long-term weight loss is heterogeneous among individuals following different procedures 3 , and the metabolic improvements underlying T2D remission are only partially explained by weight loss 4 .”
Predictors of Success in Bariatric Surgery
Masnyj, S. V., Shea, B. J., & Khaitan, L. (2020) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-020-0637-6 · Cited by 9
Pajecki, D., Kawamoto, F. M., Dantas, A. C. B., Andrade, P. C., Brasil, N. C., Junqueira, S. M., de Oliveira, F. M. P., Ribeiro, R. A., & Santo, M. A. (2020) · Clinics · doi:10.6061/clinics/2020/e1588 · Cited by 10
“Our findings are also consistent with those reported by a recent study describing the long-term (7 years) weight change and health status following Roux-en-Y gastric bypass and laparoscopic adjustable gastric banding (17), which show sustained weight loss and comorbidity remission specifically with bypass procedures.”
ResultStenberg, E., Forsberg, L., Hedström, A. K., Hillert, J. A., & Näslund, E. B. (2021) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2021.02.013 · Cited by 9
Metabolic and Inflammatory Profiles of Post-Bariatric Patients with Weight Recidivism
Lopes, K. G., Romagna, E. C., da Silva, D. S., Bezerra, M. D. C. T., Leal, P. R. F., Pinto, J. E. D. S. S., Bouskela, E., de Souza, M. D. G. C., & Kraemer‐Aguiar, L. G. (2022) · Obesity Surgery · doi:10.1007/s11695-022-06025-9 · Cited by 10
Jeong, H., Hapenciuc, G., Meza, E., Le, J. T., Heinberg, L. J., & Marek, R. J. (2023) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2023.02.014 · Cited by 9
Duarte, A. C. S., da Silva, N. R., Gonçalves, V. S. S., Corgosinho, F. C., de Carvalho, K. M. B., & Horst, M. A. (2023) · Current Obesity Reports · doi:10.1007/s13679-023-00514-3 · Cited by 9
Demaeyer, N., & Bruyneel, M. (2024) · Nature and Science of Sleep · doi:10.2147/nss.s448346 · Cited by 9
Unintended consequences for patients denied bariatric surgery: a 12-year follow-up
Kappus, M. S., Phillips, B. T., Zenquis, N., Larionova, E., Cudmore, J., & Jones, D. B. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2020.06.050 · Cited by 9
Varban, O. A., Bonham, A. J., Stricklen, A. L., Ross, R., Carlin, A. M., Finks, J. F., & Ghaferi, A. A. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05397-8 · Cited by 9
Ockham’s razor and the metabolic syndrome
Pories, W. J., Jones, T. E., Houmard, J. A., DeMaria, E. J., & Dohm, G. L. (2021) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2021.04.004 · Cited by 9
Self-citationRural/urban weight‐loss outcomes following bariatric surgery
Bauman, V., Apostolopoulos, A. N., Hasse, G. L., Parkman, T. J., & Ross, K. M. (2021) · Obesity Science & Practice · doi:10.1002/osp4.515 · Cited by 9
Decision Regret after Laparoscopic Sleeve Gastrectomy—5 Years’ Perspective
Bartosiak, K., Janik, M. R., Kowalewski, P., Walędziak, M. S., & Kwiatkowski, A. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05480-0 · Cited by 9
“Bariatric surgery is a highly effective treatment option for patients with severe obesity [2, 3].”
BackgroundHealth state utilities associated with weight loss in type 2 diabetes and obesity
Boye, K. S., Matza, L. S., Stewart, K. D., Andrews, H., Howell, T. A., Stefański, A., Malley, K. G., Ishak, K. J., & Landó, L. F. (2021) · Journal of Medical Economics · doi:10.1080/13696998.2021.2002062 · Cited by 9
Bartosiak, K., Janik, M. R., Walędziak, M. S., Paśnik, K., & Kwiatkowski, A. (2022) · Obesity Surgery · doi:10.1007/s11695-022-06113-w · Cited by 9
Emiliano, A. B., Lopatinsky, N. R., Kraljević, M., Higuchi, S., He, Y., Haeusler, R. A., & Schwartz, G. J. (2022) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00017.2022 · Cited by 9
Bjerkan, K. K., Sandvik, J., Nymo, S., Græslie, H., Johnsen, G., Mårvik, R., Hyldmo, Å. A., Kulseng, B. E., Høydal, K. L., & Hoff, D. A. L. (2022) · Obesity Surgery · doi:10.1007/s11695-022-06187-6 · Cited by 9
“About one in four of the patients undergoing RYGB procedure in the Longitudinal Assessment of Bariatric Surgery (LABS) study did not achieve 20% weight reduction from operation to 7-year follow-up [4].”
Background
Metadata
- Authors
- Courcoulas, A. P., King, W. C., Belle, S. H., Berk, P., Flum, D. R., Garcia, L., Gourash, W., Horlick, M., Mitchell, J. E., Pomp, A., Pories, W. J., Purnell, J. Q., Singh, A., Spaniolas, K., Thirlby, R., Wolfe, B. M., & Yanovski, S. Z.
- Affiliations
- University of Pittsburgh Medical Center (US)
- University of Pittsburgh (US)
- Columbia University (US)
- University of Washington (US)
- University of North Dakota (US)
- National Institute of Diabetes and Digestive and Kidney Diseases (US)
- Neuropsychiatric Research Institute (US)
- Weill Cornell Medicine (US)
- East Carolina University (US)
- Oregon Health & Science University (US)
- Corresponding author
- Courcoulas, Anita P.
- ORCID
- Venue
- JAMA Surgery
- Publisher
- American Medical Association (AMA)
- Published
- 2018-05-01
- Volume
- 153
- Issue
- 5
- Pages
- 427
- ISSN
- 2168-6254 (ISSN-L)
- PMC
- PMC6584318
- OpenAlex
- W2771736595
- Cited by
- 699
- References
- 18
- Citations by year
- 2026: 63 · 2025: 70 · 2024: 77 · 2023: 92 · 2022: 93 · 2021: 102 · 2020: 97 · 2019: 69 · 2018: 35
- FWCI
- 56.28
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA Surgery (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (U01DK066471, U01DK066557, U01DK066526, U01DK066568, U01DK108320, U01DK066667, U01DK066585)
- National Center for Research Resources (UL1RR024153, M01RR000037, UL1RR024996)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Surgery › Body Contouring and Surgery
- Health Sciences › Medicine › Surgery › Minimally Invasive Surgical Techniques
- Keywords
- bariatric surgery, Roux-en-Y gastric bypass, laparoscopic adjustable gastric banding, weight loss, weight regain, diabetes remission, dyslipidemia, hypertension, obesity, metabolic surgery outcomes, body mass index
- MeSH terms
- Body-Weight Trajectory, Adult, Aged, Female, Follow-Up Studies, Health Status, Humans, Male, Middle Aged, Obesity, Morbid, Retrospective Studies, Time Factors, Weight Loss, Body Mass Index, Treatment Outcome, Bariatric Surgery, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review